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Purpose: To compare the effectiveness of pars plana vitrectomy (PPV) with either silicone oil 
or gas tamponade for the treatment of traumatic macular holes.
Methods: A retrospective comparative study included 22 patients who were operated on by 
PPV for repair of traumatic macular holes with either silicone oil tamponade (nine patients) or 
perfluoropropane (C3F8) gas tamponade (13 patients).
Results: Twenty-two cases were reviewed to assess the anatomical and visual outcomes of 
surgery with silicone oil tamponade in nine cases (40.9%) vs 14% C3F8 gas tamponade in 
13 cases (59.1%). The age of the silicone oil-treated patients ranged from 10 to 40 years (mean 
27.4 ± 11.3 years), while that of the gas-treated patients ranged from 19 to 35 years (mean 
26.54 ± 5.68 years). Female patients accounted for 33.3% of the silicone oil group and 30.77% 
of the gas-treated group. The minimal follow-up time for the silicone oil-treated group was 
13 months, with a maximum of 18 months after silicone oil removal. The minimal follow-up 
time for the gas-treated group was 12 months and the maximum was 24 months. The rate of 
hole closure after the primary operation with oil tamponade was significantly lower than that 
with gas tamponade (66.67% vs 92.3%; P = 0.022). With re-operations, the final rate of hole 
closure was higher in the gas group (100%) than in the silicone oil group (77.8%). The final 
postoperative decimal visual acuity for the gas group was significantly better than for the oil 
group (0.433 vs 0.245; P = 0.047).
Conclusions: C3F8 gas was a more effective tamponade than silicone oil in achieving initial 
closure of traumatic macular holes. Eyes receiving an oil tamponade required significantly more 
re-operations to achieve hole closure than did eyes undergoing a gas tamponade. Final visual 
acuity was better for gas-treated eyes than for silicone oil-treated eyes.
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Introduction
Macular holes may be idiopathic, traumatic, myopic or due to other uncommon 
causes.1
Marked progress in the treatment of macular holes has occurred in recent years, 
moving from no treatment in 19892 to a .90% success rate in closing these holes by 
vitreoretinal surgery with or without adjunctive materials.3–8
Post-traumatic macular holes constitute about 5%–10% of all types of macular 
holes. They develop due to many causes including subfoveal hemorrhage, contusion 
necrosis and/or vitreous traction,9 and can be successfully closed with the same 
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The repair of traumatic macular holes has traditionally 
been accomplished by vitrectomy with gas tamponade and 
strict face-down positioning. Many patients were unable to 
tolerate this difficult postoperative position requirement due to 
physical or medical reasons. Therefore, alternative materials 
to gas tamponade were developed, including silicone oil.1–3
Patients and methods
A retrospective comparative study was done from November 
1998 to August 2010. During this period, 34 cases were   operated 
upon for closure of traumatic macular holes. Twelve cases were 
excluded from the study due to the lack of at least 1 year’s 
follow-up after the last surgical procedure, or the presence 
of associated retinal detachment. Twenty-two cases were 
reviewed to assess anatomical closure using optical coherence 
tomography (OCT) and visual outcomes after surgery with 
silicone oil tamponade or 14% C3F8 gas tamponade. Silicone 
oil was used as a tamponade in children; large holes; conditions 
preventing strict face-down position; or in patients unwilling 
to undertake the strict positioning. A thorough history from 
the patient was taken. Ophthalmological examination was 
done as follows: best corrected visual acuity using a Snellen’s 
chart; intraocular pressure using an applanation tonometer; 
slit lamp examination of the anterior segment of the eye; and 
biomicroscopy of the posterior segment using the Goldman 
3-mirror contact lens. Binocular indirect ophthalmoscopy with 
or without indentation was used to examine the periphery of 
the retina. OCT was conducted using Stratus OCT (v 4.0.7; 
Carl Zeiss, Meditec, Inc, Dublin, CA).
Case 1: traumatic macular hole and 
silicone oil tamponade
Preoperative OCT of traumatic macular hole was done 
(Figure 1) and repeated after silicone oil removal (Figure  2).
Case 2: traumatic macular hole and C3F8 
tamponade
Preoperative OCT of traumatic macular hole was done 
(Figure 3) and repeated after gas absorption (Figure 4).
The operative procedure was discussed in detail with all 
patients or their relatives and written consent was signed. 
Silicone oil was used as a tamponade in children or adults 
unwilling to adopt the strict face-down position, and for 
large macular holes.
All surgeries were performed under general anesthesia 
and by the same surgeon (H.G.). Standard three-port 
sclerotomies were done, followed by subtotal vitrectomy 
creating a posterior vitreous detachment if one was not 
already present. The suction mode of the vitrectomy cutter 
was used for this purpose.
The internal limiting membrane (ILM) was removed, 
using Eckardt end-gripping pick forceps, pinching the ILM 
about 2 disc diameters away from the foveal centre. Rhexis 
of the ILM was done leaving the foveal side till the end. 
The aim was to peel at least 2 disc diameters area of ILM 
360° around the hole. No dye was used to stain the ILM.   
In the last few years we used Triamcinolone acetonide for 
better ILM visualization during rhexis.
For the gas-treated eyes, a 20 mL syringe containing 14% 
perfluoropropane gas was connected to the infusion cannula, 
and 17 mL was injected through the infusion cannula while 
gas and air were allowed to escape from the superior tempo-
ral sclerotomy site. The sclerotomy site was closed with 7-0 
vicryl sutures. The infusion cannula was removed and the 
sclerotomy closed with 7-0 vicryl sutures. The conjunctiva 
was also closed with 7-0 vicryl sutures. Combined antibiotic–
steroid drops (tobramycin 0.3% with dexamethasone 0.1%) 
and atropine drops were applied.
Postoperatively, combined antibiotic-steroid drops 
(tobramycin 0.3% with dexamethasone 0.1%) were applied 
six times a day for 4 weeks and atropine drops were applied 
three times a day for 2 weeks.
For gas-treated eyes the patient was instructed to position 
his/her face down until 50% of the gas was absorbed, or for 
at least 2 weeks.
For silicone-treated eyes, the patient was instructed to 
position his/her face down as much as possible (at least 50% 
of the day time) for 2 weeks.
Gas-treated patients were followed up the day after the 
operation, then after 1 week, then every month until the gas 
was absorbed, then every 2 months for at least 1 year after 
the last surgery. Silicone oil-treated eyes were followed up at 
least 1 year after silicone oil removal. Results were collected, 
tabulated, and statistically analyzed.
Results
Thirty-four cases were operated on during the study 
period. Twelve cases were excluded from the study due 
to the lack of at least 1 year of follow-up after the last 
surgical intervention, or due to the presence of associated 
rhegmatogenous retinal detachment. The 22 remaining 
cases were reviewed: nine cases (40.9%) with silicone 
oil tamponade vs 13 cases (59.1%) with 14% C3F8 gas 
tamponade. The age of the silicone oil-treated patients 
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that of the gas-treated patients ranged from 19 to 35 years 
(mean 26.54 ± 5.68 years).
Female patients accounted for 33.3% (three of nine) of 
the silicone oil group and 30.77% (4 of 13) of the gas-treated 
group. The mean follow-up time in months for the silicone 
oil-treated group was 14.22 ± 1.72, ranging from 12 to 
18 months after silicone oil removal. The mean follow-up 
time in months for the gas-treated group was 14.46 ± 3.43, 
ranging from 12 to 24 months (Table 1).
Closure rates
In the silicone oil-treated group, six of nine (66.67%) of 
traumatic macular holes were sealed after the primary 
operation, while 12 of 13 (92.3%) of the gas-treated group 
were sealed in a single operation. The overall primary 
closure rate was 81.8% (18 of 22). The nonclosure rate for 
the silicone oil group was 33.3% (three of nine). One case 
closed after a second operation in which proper removal of 
any epiretinal membranes was done, followed by C3F8 injected 
as a tamponade. The other two cases could not be closed after 
a second operation, leaving a nonclosure rate of 22.2%. The 
nonclosure rate for the gas-treated group was 7.7% (one of 
13), in which the hole closed after a second operation in which 
removal of any epiretinal membranes was done and gas was 
re-injected as a tamponade. Including reoperations, the final 
rate of hole closure was 100% (13 of 13) in gas-treated eyes 
and 77.8% (7 of 9) in the silicone oil-treated eyes (Table 2).
Visual outcomes
The pre-operative decimal visual acuity was 0.067 for the 
silicone oil group and 0.061 for the gas-treated group. The 
postoperative decimal visual acuity at 4 weeks was 0.126 for 
the silicone oil group and 0.255 for the gas-treated group. The 
postoperative decimal visual acuities at 6 months were 0.226 
for the silicone oil group, while the postoperative decimal visual 
acuities at 6 months were 0.355 for the gas-treated group.
The postoperative decimal visual acuity at 1 year was 
0.245 for the silicone oil group and 0.433 for the gas-treated 
group (Table 3).
Adverse events
Two cases (22.2%) in the silicone oil group had permanent 
nonclosure of the macular hole. One case in the gas-treated 
group had a postoperative day 1 intraocular pressure of 
48 mmHg that was controlled by a combination of dorzol-
amide and timolol topical anti-glaucoma therapy twice daily 
for 2 weeks. None of the cases in the study developed post-
operative retinal detachment or endophthalmitis. The occur-
rence of cataract was 44.4% (four of nine) for the silicone oil 
group and 46.15% (six of 13) for the gas-treated group.
Discussion
Twenty-two cases of traumatic macular hole repair, reviewed 
in a retrospective comparative study from November 1998 to 
August 2010, showed a higher closure rate for gas-treated eyes 
(92.3%: 12 of 13) than for silicone oil tamponade (66.67%: six 
of nine) in a single operation. The overall primary closure rate 
for traumatic macular holes was 81.8% (18 of 22). The final 
hole closure rate was 100% for the gas-treated group vs 77.8% 
for the silicone treated group. The lower rate of hole closure by 
Table 1 Demographics
Silicone oil group C3F8 gas group P value
no 9 40.9% 13 59.1%
Age range Mean ± sD range Mean ± sD .0.05
10–40 27.4 ± 11.3 19–35 26.54 ± 5.68
sex Female (3) Male (6) Female (4) Male (9) .0.05
% 33.3% 66.7% 30.77% 69.23%
Follow-up  
(months)
Range
12–18
Mean ± SD
14.22 ± 1.72
Range 
12–24
Mean ± SD 
14.46 ± 3.43
 
.0.05
Table 2 Closure rate
Hole closure Silicone oil Gas (C3F8) X2 P value
No. (9) % No. (13) %
single operation 6 66.7% 12 92.3%
2nd operation 1 11.1% 1 7.7% 3.385 .0.05
nonclosure 2 22.2% 0 0%
Table 3 Visual outcomes
Silicone oil Gas (C3F8) T P value
Preoperative mean VA 0.067 0.061 1.537 .0.05
Postoperative mean VA
  1 month 0.126 0.255 2.757 ,0.05
  6 months 0.226 0.355 2.864 ,0.05
  1 year 0.245 0.433 3.983 ,0.05
Notes: P . 0.05 = not significant; P , 0.05 = significant.
Abbreviations: VA, visual acuity; T, student’s t-test.Clinical Ophthalmology 2012:6 submit your manuscript | www.dovepress.com
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silicone oil tamponade might be due to: the nature of the cases, 
as silicone oil was used for large traumatic macular holes; the 
lower surface tension of the silicone oil as compared with 
that of the gas; or patients’ unreliability in maintaining a strict 
postoperative face-down position, particularly in children.25
Closure rates in this study were favorable compared 
with previous reports of idiopathic or myopic macular hole. 
This may be due to the fact that traumatic macular holes 
have better recovery rates than other types of macular holes. 
Healing may also be better in younger patients, and the early 
diagnosis of traumatic macular holes compared to other types 
of macular holes may help to improve the outcome.19–21
For silicone-treated eyes the final success rate (77.8%) 
is less than that reported by Goldbaum et al7 who obtained 
an 83% silicone oil seal rate for idiopathic macular holes, 
and considerably less than the 97% reported previously 
by Pertile and Claes15 for idiopathic macular holes. Our 
silicone oil closure rate was higher than the 50% closure 
rate of idiopathic macular holes described by Voo et al.16 
When comparing our final closure rates for gas-treated eyes 
(100%) to previous studies, they were higher than the 58% 
seal rate first described by Kelly and Wendel17 and the 69% 
seal rate described by Freeman et al.18 This might be due to 
the fact that the macular holes in these studies were idio-
pathic and not traumatic macular holes as in our study.
The pre- and postoperative visual acuities were reviewed. 
The average pre-operative visual acuity was slightly worse 
in the silicone oil group compared to the gas-treated group. 
Each group showed a gradual improvement in visual acuities 
at 4 weeks, 6 months, and 1 year.
After 1 year the silicone oil group improved from 0.126 
to 0.245, while the gas-treated group improved from 0.255 
to 0.433. These findings correlate to a 3-line ETDRS visual 
acuity chart increase with silicone oil repair and a 4-line 
increase with gas repair. Goldbaum et al7 had a 3–4-line 
improvement with silicone oil closure of idiopathic macular 
holes but not in traumatic macular holes. The better visual 
outcomes in gas-treated eyes than in silicone-treated eyes 
may be due to the fact that silicone oil is in contact with the 
bare retinal pigment epithelium (RPE) and photoreceptors in 
macular hole surgery and has been found to be toxic to RPE 
and photoreceptors in previous studies.22–25
Figure 1 Preoperative OCT of traumatic macular hole with silicone oil tamponade.
Figure 2 Postoperative OCT of traumatic macular hole with silicone oil tamponade 
after oil removal.
Figure 3 Preoperative OCT of traumatic macular hole with C3F8 gas.
Figure 4 Postoperative OCT of traumatic macular hole with C3F8 gas.Clinical Ophthalmology
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In this study we concluded that gas tamponade is more 
successful in anatomical closure of traumatic macular holes 
than silicone oil tamponade. Eyes with traumatic macular 
holes surgically repaired with gas tamponade showed sig-
nificant improvement in visual acuity compared with eyes 
treated with silicone oil tamponade.
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